Financial reports
10-Q
2024 Q2
Quarterly report
12 Feb 24
10-Q
2024 Q1
Quarterly report
9 Nov 23
10-K
2023 FY
Annual report
15 Sep 23
10-Q
2023 Q3
Quarterly report
11 May 23
10-Q
2023 Q2
Quarterly report
10 Feb 23
10-Q
2023 Q1
Quarterly report
10 Nov 22
10-K
2022 FY
Annual report
13 Sep 22
10-Q
2022 Q3
Quarterly report
12 May 22
10-Q
2022 Q2
Quarterly report
10 Feb 22
10-Q
2021 Q1
Quarterly report
10 Nov 21
Current reports
8-K
Results of Operations and Financial Condition
12 Feb 24
8-K
Submission of Matters to a Vote of Security Holders
27 Nov 23
8-K
Results of Operations and Financial Condition
9 Nov 23
8-K
Results of Operations and Financial Condition
15 Sep 23
8-K
Results of Operations and Financial Condition
11 May 23
8-K
Integrated BioPharma Announces the Sudden Death of Its Executive Chairman and President
21 Mar 23
8-K
Entry into a Material Definitive Agreement
17 Mar 23
8-K
Results of Operations and Financial Condition
10 Feb 23
8-K
Entry into a Material Definitive Agreement
6 Dec 22
8-K
Submission of Matters to a Vote of Security Holders
28 Nov 22
Registration and prospectus
S-8
Registration of securities for employees
28 Dec 18
D
$5.35M in debt / securities to be acquired, sold $5.35M, 1 investor
11 Jul 12
25
Voluntary exchange delisting
13 Apr 09
424B3
Prospectus supplement
6 May 08
S-3/A
Shelf registration (amended)
29 Apr 08
S-3/A
Shelf registration (amended)
17 Apr 08
S-3/A
Shelf registration (amended)
16 Apr 08
S-3
Shelf registration
21 Mar 08
REGDEX
Notice of sale of securities
7 Mar 08
RW
Registration withdrawal request
23 Aug 07
Proxies
DEF 14A
Definitive proxy
27 Oct 23
DEF 14A
Definitive proxy
27 Oct 22
DEF 14A
Definitive proxy
27 Oct 21
DEF 14A
Definitive proxy
28 Oct 20
DEF 14A
Definitive proxy
28 Oct 19
DEF 14A
Definitive proxy
29 Oct 18
DEF 14A
Definitive proxy
27 Oct 17
DEF 14A
Definitive proxy
28 Oct 16
DEF 14A
Definitive proxy
26 Oct 15
DEF 14A
Definitive proxy
28 Oct 14
Other
UPLOAD
Letter from SEC
4 Aug 08
EFFECT
Notice of effectiveness
2 May 08
CORRESP
Correspondence with SEC
30 Apr 08
UPLOAD
Letter from SEC
22 Apr 08
UPLOAD
Letter from SEC
27 Mar 08
UPLOAD
Letter from SEC
27 Mar 08
UPLOAD
Letter from SEC
13 Mar 08
EFFECT
Notice of effectiveness
11 Jul 07
CORRESP
Correspondence with SEC
10 Feb 05
UPLOAD
Letter from SEC
18 Jan 05
Ownership
4
SHEPPARD RIVA
29 Nov 23
4
CHRISTINA KAY
29 Nov 23
4
Dina Masi
29 Nov 23
SC 13D
INTEGRATED BIOPHARMA / INTEGRATED BIOPHARMA ownership change
16 Nov 23
5
E GERALD KAY
16 Nov 23
3
Gerald Kay Estate Edward
16 Nov 23
SC 13D
INTEGRATED BIOPHARMA / INTEGRATED BIOPHARMA ownership change
14 Nov 23
4
SHEPPARD RIVA
21 Sep 23
4
CHRISTINA KAY
21 Sep 23
4
Dina Masi
21 Sep 23